Overview

Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer

Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to define the response and toxicities with the addition of Nimotuzumab to chemoradiation for head and neck cancer.
Phase:
Phase 2
Details
Lead Sponsor:
National Cancer Centre, Singapore
Collaborator:
Innogene Kalbiotech Pte. Ltd
Treatments:
Cisplatin
Nimotuzumab